| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.008 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.17 | 0.01 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |